Bristol Myers Squibb
Sotyktu
psoriasis
Resolved
123days ago
Approval decision · Mar 6, 2026
What's at stake
A final FDA approval decision on Sotyktu for psoriasis is expected Mar 6, 2026.
Primary source
· SEC 8-K
verified 14h ago
“The FDA approved Sotyktu for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.”